The objective of this note is to introduce a clinical tool that generates ideal base plan dose distributions to enable re-irradiation volumetric modulated arc therapy (VMAT) optimization based on cumulative biological effective dose objectives for specific organs at risk (OARs). The tool is demonstrated with a lung cancer case that required re-irradiation at our clinic. First, previous treatment dose is deformed onto the retreatment computed tomography (CT) using commercial software. Then, the in-house Matlab tool alters the deformed previous dose using radiobiological concepts on a voxel-by-voxel manner to generate an ideal base plan dose distribution.
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Ideal base plans that were generated using the in-house Matlab tool were compatible with the Varian Eclipse™ treatment planning system. The tool enabled optimization of VMAT re-irradiation plans using cumulative dose limits for OARs and all OAR cumulative dose objectives were met on the first optimization for the recurrent lung cancer case tested. In addition, computer software capable of converting voxel doses using the linear-quadratic model (LQM) 2 to calculate biologically effective dose (BED) distributions is now commercially available. 3, 4 radiation oncologists to account for nonlinear biological response to differing dose-per-fraction. 4 Moreover, BED distributions are theoretically additive according to the LQM -meaning distributions from separate courses of treatment can be summed to quantify cumulative BED for each voxel. [3] [4] [5] [6] The mechanistic LQM is often considered to be over simplistic 7 ; however, it is almost universally used to adjust for fraction size because it is practical, biologically based and acceptably accurate for dose-per-fractions below 15 Gy.
2,8
Based on recent reports, a growing number of radiation oncologists are using cumulative BED distributions to guide their re-irradiation plan evaluation. 3, 6 Several institutions have reported OAR toxicity along with cumulative BED metrics in lung cancer patients receiving re-irradiation, 9,10 with some instances of severe toxicities after delivering high cumulative dose to the aorta, 11,12 esophagus, 9, 13 and lungs. [14] [15] [16] This clinical evidence has motivated radiation oncologists to prescribe cumulative BED limits for specific OARs. In this technical note, we introduce a clinical tool that enables direct VMAT optimization of cumulative dose objectives using an ideal base plan dose that is compatible with a commercial TPS. Our proposed tool manipulates previously delivered dose to circumvent conventional base plan limitations and help guide VMAT optimization of re-irradiation. Specifically, ideal base plans restore the ability to monitor whether cumulative dose objectives are achieved using the evolving sum DVHs throughout optimization. The tool is demonstrated retrospectively for a lung cancer case where re-irradiation was prescribed. 
| METHODS AND RE SULTS 2.A | Patient data

2.B | CT 1 -to-CT 2 deformable image registration
An overview of the re-irradiation planning workflow that incorporates the proposed tool is shown in Fig. 1 
2.C | Generation of base plan
The tool is an in-house Matlab (The Mathworks Inc., Natick, MA, USA)
program that manipulates D 1_onCT2 to generate an ideal base plan dose for re-irradiation optimization, referred to as D 1_baseplan . The tool requires user-specified initial course prescription (R x1 ) in Gy, the number of fractions for initial (n 1 ) and re-irradiation (n 2 ) courses, and OARspecific priorities and α/β ratios. In addition, the tool requires a cumula- 
2.C.1 | OAR base plan dose
For each OAR, D 1_onCT2 is converted voxel-by-voxel to a physical dose in Gy per n 2 fractions equal to the radiobiological fraction of D L previously delivered by initial treatment. To do this, D L is converted to BED (BED L ) using the LQM formalism 2, 19 :
Similarly, D 1_onCT2 is converted to BED (BED 1 ) for all voxels.
Then, for each voxel with BED 1 < BED L , the allowed re-irradiation voxel dose is defined as D allowed = d allowed × n 2 , with d allowed calculated using the equality:
and then, D 1_baseplan voxel dose is set to D L − D allowed .
Here, we highlight two important points regarding voxels with calculated using the equality:
The isoeffective dose conversion essentially scales D 1_onCT2
dose to the re-irradiation fractionation such that it will correctly appear above D L on the sum DVH throughout the entire optimization. It must be recognized that none of the OAR sum DVH values represent true physical or biological dose when D 1_baseplan is used. However, each sum DVH may be regarded as a LQM-scaled approximation that accurately reports whether D L is satisfied.
2.C.2 | PTV 2 base plan dose
All voxels labeled as PTV 2 are set to an arbitrary uniform dose in Finally, D 1_baseplan is saved as a DICOM dose file, using the original dose files' DICOM header information. The Matlab-generated DICOM base plan dose files are then imported to the version 13.0 Eclipse ™ TPS.
2.D | Re-irradiation VMAT optimization
The re-irradiation plan consisted of two full coplanar arcs placed at the center of PTV 2 . For the recurrent lung case, D 1_baseplan was generated using tool inputs: R x1 /n 1 = 60/30, n 2 = 4 along with all OARspecific priorities, α/β, and D L listed in Table 1 . Optimization dose objectives were set according to prioritized cumulative dose limits in Gy per n 2 fractions listed in Table 1 . Since PTV 2 voxel dose is 0 Gy in D 1_baseplan , PTV 2 lower dose objective is set to R x2 (48 Gy).
2.E. | Re-irradiation plan evaluation
After optimization, D 2 and D 1_onCT2 were converted to BED using MIM software and the cumulative BED was calculated. Cumulative dose limits were satisfied and OAR-specific sum BED metrics are reported in Table 1 . For the re-irradiation plan only, the percent volume of PTV 2 that received ≥100% of the R x2 (V 100% ) was 99.9% and the D max was 128% (61.6 Gy), which is acceptable for SABR treatment at our clinic. by the treating physician. 7, 21 Finally, planned re-irradiation dose distributions must always be evaluated alone in addition to the cumulative BED distribution prior to re-irradiation commencement.
In this work, a tool was shown to facilitate optimization of VMAT re-irradiation plans using cumulative dose limits for OARs. Ideal base plans generated using our tool were compatible with the Varian Eclipse ™ TPS and similar tools could be developed for other TPSs that accommodate base plans. The presented tool may also be used for inverse-planning of IMRT plans as long as base plans can be used during optimization. Although the underlying algorithm used to create the ideal base plan is complex, the tool is clinically practical because it only requires simple OAR-specific inputs to generate an ideal base plan for each patient. Furthermore, use of the ideal base plan eliminates timeconsuming iterations of plan optimization, dose conversion to BED and BED accumulation to verify whether cumulative dose objectives are achieved or not. Future work will aim to incorporate representation of dosimetric uncertainties associated with deformable IR errors during cumulative dose evaluation. 22 Furthermore, a script will be developed using Eclipse scripting Application Programming Interface to streamline clinical use of this tool. Finally, we will investigate potential improvements in planning time required and overall plan quality introduced by the proposed planning approach.
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